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A large number of activator proteins have now been identified in higher and lower eukaryotes, which bind to the regulatory rcpjons of protein. 
encoding enes and increase the rate at which tbcy are transcribed by RNA polymerasc II. The mechanism by which activators function is being 
intensively studied and some of the targets of transcriptional ctivation domains have now been identified. These studies have also revealed novel 
classes of regulatory factors, which were not anticipated by extrapolating from the principles obtaira!! with prokaryotic promoters. 
Activator: RNA polymerasc 11; Mechauism of activation; General transcription faclor; Coactivalor 
1. INTRODUCTION 
A major goal in the field of eukaryotic gene regula- 
tion is to understand how the activator proteins that 
bind to the upstream promoter elements and enhancers 
of RNA polymerase II-dependent genes stimulate the 
rate at which these genes are transcribed. RNA polym- 
erase II is unable to recognize promoters on its own and 
is assisted by a number of accessory proteins, referred 
to as the general transcription factors. A simple hypoth- 
esis is that transcriptional activators directly interact 
with either RNA polymerase 11 or one or more of the 
general transcription factors, and thereby stimulate the 
rate of formation or activity of the transcription initia- 
tion complex or increase the number of complexes 
formed (see [l] for a discussion of this and alternative 
ideas). Here, we will discuss the results of a number of 
experiments hat have attempted to identify the targets 
of transcriptional activation domains. However, it is 
important o recall that eukaryotic genes are associated 
with histones in vivo, which have been found to exclude 
the general transcription factors from the promoter 
both in ,rivo and in vitro and which appear to have a 
repressive ffect on transcription. Therefore activator 
proteins might also stimulate transcription by altering 
chromatin structure so as to make the promoter accessi- 
ble to RNA polymerase II and its associated factors. 
Evidence in favour of this hypothesis has recently been 
reviewed elsewhere [2]. 
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2. THE TRANSCRlPTION INITIATION COM- 
PLEX 
The region of a promoter in which the RNA polym- 
erase 11 transcription initiation complex is assembled 
Arid where transcription initiates is known as the core 
or minimal promoter (Fig. 1). Usually this contains a 
TATA box sequence [3], which specifies the direction of 
transcription and the site of initiaiion, and which will 
allow a basal level of transcription in vitro. In addition 
to the TATA box, or as an alternative, some core pro- 
moters contain sequences around the initiation site (ini- 
tiators) which can also direct the assembly of an initia- 
tion complex (see [4]). The general transcription factors 
were originally defined as factors necessa.ry for the in 
vitro transcription of core promoters by RNA polym- 
erase II, and were thought o be required by all promot- 
ers. General transcription factors wem identified by 
chromatographically fractionating extracts prepared 
from cell lines or tissues and testing the importance of 
particular fractions for transcription in ,vitro. Most of 
the general transcription factors have now been purified 
to homogeneity and cDNAs encoding the polypeptides 
associated with particular activities have been isolated 
(see [5,6] and Table I. 
The transcription initiation complex is assembled in 
a temporally ordered fashion [21-231. The first event is 
the binding of TFIID to the TATA box sequence. In 
contrast to many activator proteins, TFIID binds 
slowly to the promoter, but once formed, the TFIID- 
TATA box complex is very stable (see [24] for refs.). The 
binding of TFIID is facilitated by another factor, 
TFIIA, which is unable to bind to the promoter on its 
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activator protalns prelnltletlon complex 3. TFIID AND TFIIB AS TARGETS OF ACTIVA- 
TION DOMAINS 
3.1. The htportuttce oJ TFiiD 
TFIID has attracted considerable attention as a po- 
tential target for transcriptional ctivators, since it ap- 
pears to play a crucial role in the assembly of the tra.n- 
scription initiation complex on all promoters tested so 
far in vitro. In the case of core promoters with a TATA 
box, TFIID is the only general transcription factor 
which can specifically recognize the promoter on its 
own. The binding of TFIIB, Pol II, TFIIE and TFlIF 
depends on the prior formation of a TFIID-TATA box 
complex (see, for example, [X!]). which 
tain initiator but a box 
require [27,2S], may recruited the 
by of direct with 
[61. 
upstream 
elements 
promoter 
I. of RNA-polymeruse preinitiation on 
typical promoter. binding the binding 
(TBP). is of to TATA (consensus 
is by in promoter an 
(INR) at +l The assembly of TFIIB, 
followed by the RNA-polymcrasc. which is associated with TFIIE and 
TFIIF creates an active preinitiation complex (PIG). In a promoter 
containing INR scquznccs (consensus YAYTCYYY. where Y=pp 
rimidinc), TFII-1 is able to substituie for TFIIA, indicalingaltcrnativc 
pathways for PIC formation. whereas in a TATA4css promoter, TFII. 
I is necessary for TFIID binding. The assembly of the PIC might be 
facilitated by the action of transcriptional trnnsactivator proteins. 
They usually bind as homodimcrs to their binding sites (BS) located 
upstream (or downstream) ofthe TATA-box and might activate Iran- 
scription by contacting one or more of the &cncral transcription fat- 
tars. Activator proteins arc composed of distinct domains, a DNA- 
binding and dimerieation domain and a transactivation domain, 
which may be separated by a binge region, Sonic aciivalors do not 
bind to specific DNA sequences and recognize the promotrr by inter- 
acting with otbcr transcription factors already bound to the DNA c,g. 
VP16 interacts with OCTI and Ela binds to ATF. 
own. Once the D-A complex is formed, TFIIB binds to 
the promoter downstream of the TATA box over the 
initiation site. The D-A-B complex is then recognized 
by RNA polymerase II in association with TFIIE and 
TFlIF. This complex is functionally analogous to the 
prokaryotic losed complex. Transcription initiation re- 
quires hydrolysis of ATP and leads to melting of pro- 
moter DNA and open complex formation [25] followed 
by mRNA initiation and elongation. In theory, any of 
the steps in the assembly of the preinitiation complex 
could be rate limiting on a particular promoter in viva 
and might be a target for transcriptional ctivator pro- 
teins. Originally the general transcription factors were 
thought to be required by all polymerase II promoters. 
However, the situation is probably more complex than 
this. For example, anew factor has been isolated, TFII- 
I, which binds to the initiator and can functionally re- 
place TFlIA [20]. However, it can only be used by pro- 
moters that contain initiator elements. Similarly, whilst 
TFIlE is essential for transcription of the adenovirus 
major late promoter in vitro it is apparently not re- 
quired for the immunoglobulin heavy chain core pro- 
moter, which in turn requires two novel activities re- 
ferred to as 700 kDa and 90 kDa [26]. 
A number of early studies either showed that activa- 
tor proteins could alter the binding of TFIID to the 
promoter (USF:[29]; GAL4 derivatives: [30]; ATF: [31]) 
or implicated TFIID as a target (pseudo rabies virus IE 
protein: [32]). However, all of these experiments were 
performed with partially purified TFIID and therefore 
it could not be excluded that the activators interacted 
with other proteins in the TFIID fraction. Subsequent 
work has shown that TFIID is in fact a large multipro- 
tein complex consisting of a TATA box-binding protein 
(TBP) and a variable number of associated polypeptides 
referred to as TAFs (TBP associated factors; reviewed 
in [33]j. The TBP has now been cloned from several 
species (reviewed in [34]) and its structure is shown in 
Fig. 2. Recombinant TBP can efficiently bind to the 
TATA box on its own and will support basal transcrip- 
tion of a core promoter in vitro when mixed with the 
other general transcription factors. Is there any evi- 
dence to suggest that activators directly interact with the 
TBP? 
3.2, The VP16 rxtiwlor 
The VP16 protein of herpes implex virus I contains 
a transactivation domain rich in acidic amino acid resi- 
dues, and is one of the best-characterized cukaryotic 
activator proteins (see, for example [35]). In contrast o 
many other transcription factors VP1 6 does not bind to 
a specific DN.4 sequence and recognizes the promoter 
by interacting with another factor (OCTl) already 
botrnd to the DNA. Stringer et al. [36] first showed that 
both the TFIID activity in HeLa cell nuclear extracts 
and recombinant yeast TBP could speciIically bind to 
columns containing agarose beads linked to a fusion 
between protein A and the transactivation domain of 
VP1 6. However, since the TBP is relatively basic and the 
VPlG activation domain is highly acidic, it was neces- 
stir;) to show that hi.nding was not the result of a non- 
specific ionic interaction. The same group therefore 
tested the yeast TBP on columns prepared from mutant 
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VP16 proteins with reduced transcriptional activity [37]. 
Cress and Trierenberg [35] had previously shown that 
a particular phenylalanine residue in the VP16 activa- 
tion domain (Phe-442) plays a critical role in transacti- 
vation. lngles et al. [37] found that changing Phe-442 in 
the protein A-VP16 fusion proteins to other residues. 
which did not alter the overall charge of VPI 6, reduced 
the binding of the TBP by a degree comparable to the 
effect of these mutations on transactivation i vivo sug- 
gesting that the interaction was specific, However, mu- 
tation of acidic residues in VP16 had a more severe 
effect on TBP binding in vitro than on activation in 
vivo. 
At the same time Lin and Green [38] showed that a 
chimaeric activator consisting of the GAL4 DNA bind- 
ing domain fused to an amphipathic a-helix rich in 
acidic residues timulated transcription in vitro by rc- 
cruiting TFIIB to the initiation complex. rather than 
TFIID. Furthermore, they found that both TFILD and 
TFIIB bound to a glutathionc-S-transferase (GST)- 
VP16 column in buffer containing 0,l M KCI, but when 
a buffer containing 0.2 M KC1 was used only TFIIB was 
bound. This binding was abolished by mutating Phe- 
442 in VP1 6 to proline. Recombinant TFIIB expressed 
in E. cdi could also 
Irlrrrclctiotls betwcal orhcr uclivutors unri lh TBP 
Like VPl6, the i3S adenovirus El a protein is a 
potent activator which does not have a specific DNA 
binding site. It does not contain an acidic activation 
domain but has also been shown to interact directly 
with the TBP f40,41]. In these studies, the interaction 
was demonstrated in vitro by a variety of techniques: 
Ela affinity chromatography, protein-protein blotting, 
sedimentation velocity centrifugation of Ela-TBP wm- 
plexes and co-immunoprecipitation. Ela-TBP com- 
p!exes were also immunoprecipitated from cell extracts. 
although it was necessary to use cells infected with rc- 
combinant vaccinia viruses overexpressing Ela and the 
TBP. The 12s Ela protein, which is a less potent 
transactivator than the I35 form, bound the TBP more 
weakly. Similar approaches have been used to demon- 
strate that the Epstein-Barr virus Zta protein, which has 
an activation domain different to those of VP16 and 
E I a, can also directly interact with the TBP in vitro [42]. 
Finally. in our laboratory we have found that the bovine 
papillomavirus I E2 protein and the TBP bind coopera- 
tively to an oligonucleotidc ontaining an E2 site 8 bp 
from a TATA box in gel retardation assays, suggesting 
that E2 may also interact directly with the TBP [43]. 
In summary, a number of activators, some of which 
bind to specific DNA sequences (Zta and E2) and some 
of which recognize target genes by interacting with 
other transcription factors (VP16 and Ela), appear to 
interact directly with the TBP in vitro. What regions of 
the TBP are contacted? The DNA binding domain of 
the TBP contains a repeat of basic amino acid residues, 
which are predicted to fall on the same face of an CL- 
helix. It is interesting to note that TFIIB also contains 
a similar basic repeat (Fig. 2). Point mutation of these 
residues in the TBP has shown that they are not re- 
quired for DNA binding [44] but that they are impor- 
tant for interaction with TFIIA [45]. It is tempting to 
speculate that the basic residues might also be involved 
in direct interactions with activators. In fact Eta has 
Table I 
General transcription iniliation factors 
Factor 
TFIIA 
Polypcplide composilion 
Ycasu 2 subunits: 32 kDa (TOA I) 
13.5 kDa (TOA2) [7] 
Human: Trimer 01’34, 19 and 14 kDn [8] 
Funclion 
Stabilizes the binding orTBP 10 the TATA-box: not essential 
for all proniolers [32] 
TFIIB Yeast: 38 kDa [9] 
Human: 33 kDa [IO.1 I] 
promoles binding of RNA-pal. II; target ol’tranxrip~ional 
transxlivalor prowins (VP IG) [38] 
yTFIIB: rcquircd for start sire sclcclion 
TFIID 
TFIIE 
multiprolcin complex > 100 kDa composed or TAFs. 
TBP (38 kDa) (see 133.341) 
Human: lctramer, composed of two 57 kDa and 
two 34 kDa subunils [IZ-141 
TRP: binding IO lhc TATAsbox, inidal step in PIG assembly, 
large1 ol’ lransactivator proicins 
RNA pol. associated factor (RAP) 
TFIIF Human: letrumcr with two 74 kDa [l5,lG] and 
two 30 kDa subunits [I71 
small subunit interacts with RNA pal. Il. supprcs~rr binding 
of RNA pol. II LO non-promoter DNA, cnabla pal. II to bc 
recruited 10 the D-A-B complex together with TFIIE [18,19] 
TFII I Human: I20 kDa binds 10 lhc INR-clemcm, promotes TBP binding [6,20] 
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Structure of Human TBP and TFIIB 
TBP conselvod core domaln 
1 STPl 0.30 STP2 ‘% 335 
ti.EP C 
-- 
183 222 2% 312 
direct repeels 
I.. . . basic amino acids 
u slgma homology 
2.3R.4 
TFIIB 
1 316 
N.1 bC 
B_ 
122 185 PIG 222 
.,,. . ..I. 
- 
2.1R.2 
direst repeals 
bask amino acids 
sigma homology 
Fig. 2, Similarity in structural features between the human TATA- 
binding protein (TBP) and TFIIB. The carboxy-terminal 180 amino 
acids of the TBP are sufficient for DNA-binding and basal transcrip- 
tion and are evolutionarily conserved (e.g. there is 81% identity bc- 
tween the human and budding yeast TBPs). The TBP core domain 
contains two direct repeats of 39 amino acids important for DNA- 
binding. A repeat of basic amino acids with the potential to form an 
a-helix with the basic residues on one face is not required for DNA- 
binding, but might interact with certain types of activator proteins. A 
n&on which shows homology to the subregions 1.3 and 2.4 of the 0’” 
factor of I.2 coli is The non-conserved of 
the TBP is of a with 34 (Q-34), 
flanked two regions and STPZ!) in scrines threonines 
(T) prolincs (P), might serve interfaces for 
protein-protein interactions. TFIIB contains struc- 
tural to those the TBP, thut they have related 
Two direct of 76 acids, two of basic 
acids and sequence, which related to cr’O factor 
region arc 
been shown bind to proteins containing 
dues 221-271 the TBP, region which the 
basic [41]. However, Zta-TBP interaction 
to require C-terminal to region 
[42] that different domains may 
the TBP different places. 
THE ROLE COACTIVATORS 
4.1 De$k~ition of wactivcttors 
Initial studies with purified recombinant human or 
Drosophifu TBP showed that whilst they could efii- 
ciently participate in the basal transcription of core pro- 
moters in vitro they did not allow activation by the 
mammalian transcription factors SPl or USF, whereas 
TFIID partially purified from HeLa cells or Drusuplrilu 
embryos did [41%l83. This suggested that other polypep 
tides in the TFIID complex (the TAFs) play an impor- 
tant role in the process of transcriptional ctivation and 
these were therefore named coactivators. This hypothe- 
sis was recently confirmed by using urea to separate the 
TAFs from the TBP in the Drosophilu TFIID complex. 
The TBD obtained in this way was unable to mediate 
activation by SPl or the Droscpkila activator NTF-1, 
but addition of the renatured TAF fraction restored the 
activator response [49]. When the Drosopklu TFIID 
complex was immunoprecipitated with an anti-TBP an- 
tibody six major polypeptides co-precipitated. Similar 
results were obtained with human TFIID [SO]. In paral- 
lel with these studies a ‘mediator’ activity, distinct from 
the general transcription factors, was purified from 
yeast cells and shown to be necessary for the acidic 
activators GAL4VP16 and GCN4 to be able to func- 
tion efficiently in a reconstituted invitro system [51,52]. 
A similar activity, which allows transcriptional stimula- 
tion by GAL4-VP16 in a reconstituted mammalian sys- 
tem, has been isolated from HeLa cell extracts [53]. 
Exactly how coactivators/mediators facilitate tran- 
scriptional activation by activator proteins is unknown 
at present. Coactivators do not appear to bind to spe- 
cific DNA sequences and it has been suggested that they 
might act as bridging proteins between activation do- 
mains and the TBP. In this sense they would be analo- 
gous to the adenovirus Ela protein, which can specifi- 
cally bind to the ATF activator and can also interact 
directly with the TBP. Alternatively, they might facili- 
tate direct interactions between activator proteins and 
the TBP or TFIIB, or other components of the general 
transcriptional machinery. Another possible mecha- 
nism has been suggested by recent studies from R.G. 
Rocder’s group. They have isolated an activity referrsd 
to as USA (upstream factor stimulatory activity) which 
potentiates activation by SPl and USF in vitro in con- 
junction with natural TFiiD but not the recombinant 
TBP [54]. USA would therefore appear to have coacti- 
vator properties but be less tightly associated with the 
TSP than the TAFs isolated by Tjian and coworkers. 
USA was resolved into two components, NC1 (negative 
cofactor 1) and PC1 (positive cofactor I) which had 
opposite effects on core promoter activity: NC1 inhib- 
ited, whereas PC1 stimulated basal activity. Interest- 
ingly, NC1 could interact directly with the TBP and like 
TFIIA could stimulate binding of the TBP to the TATA 
box. TFLIA displaced NC1 from an NCI-TBP com- 
plex. Two other activities, NC2 (negative cofactor 2) 
and DBF4 (TFIlD binding factor 4), with similar prop 
erties to NC1 have recently been isolated [SS]. It has 
been suggested that these activities might reduce core 
promoter activity by forming non-productive com- 
plexes with TFIID and that activators might reverse this 
pathway of complex formation (see [6] for a discussion). 
5. CONCLUSIONS AND FUTURE PROSPECTS 
The hypothesis outlined at the beginning of this arti- 
cle predicts that there should be components of the 
general transcriptional machinery that are directly con- 
tacted by activator proteins. This indeed appears to be 
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the case. There is now good evidence that W16, Ela 
and ZTa specifically interact with the TBP in vitro and 
that VP16 can interact even more strongly with TFIIB. 
However, the amino acid residues and protein struc- 
tures involved in these interactions need to be defined 
more precisely. This will require detailed mutational 
analysis of transactivation domains and the regions that 
they contact in the TBP and TFIIB. The results of such 
structure/function studies will then need to be related to 
the 3D-structures of activation domains and their tar- 
gets as determined by X-ray crystallography or nuclear 
magnetic resonance. 
Another prediction of the hypothesis is that these 
interactions hould lead to an increase in the rate of 
formation of the transcription initiation complex or in 
the number of complexes formed. VP16 has been clearly 
shown to affect the recruitment of TFIIB into preinitia- 
tion complex, which was a rate limiting step in the sys- 
tem studied [38] and Zta stabilizes the binding of the 
TBP to the non-consensus TATA box (GATAAAAG) 
of the MinL promoter [42]. Analysis of the mechanism 
of transcriptional activation will be complicated be- 
cause different activators may function by different 
mechanisms and a single activator may contact more 
than one target protein or may behave differently in 
different promoter contexts. For example, the acidic 
VP16 activation domain can apparently interact with 
both the TBP and TFIIB and requires a coactivator 
activity to be able to stimulate transcription in vitro. 
This emphasizes the importance of developing simple 
model systems with well-defined components. 
Finally, a novel class of regulatory factors (coactiva- 
tors) has been identified which appears to play an im- 
portant role in the process of transcriptional ctivation. 
Neither the molecular structure nor mode of action of 
coactivators is known at present. It will be necessary to 
purify coactivator polypeptides and obtain the corre- 
sponding cDNA clones. It will also be important to 
obtain genetic evidence to support their existence. 
In the budding yeast, Sxclmon~yces crre~M~c, mu- 
tations have already been isolated in genes encoding 
activators, e.g. GAIA and GO%, as well in genes for 
some of the general transcription factors such as the 
TBP and TFIIB. Interestingly, genetic analysis of sev- 
eral different regulated genes in yeast has identified 
trans.acting loci that are required for the activation of 
large sets of genes, but which do not encode gene-spe- 
cific activators or general transcription factors. For ex- 
ample, SNF2, -5 and -6 are necessary for the efficient 
transcription of glucose-repressible g nes, acid phos- 
phatase, cell type-specific genes aud Ty elements, and 
appear to be functionally interdependent [SG]. Similarly, 
mutations in SWII, -2 and -3 not only affect the ability 
to the Ii0 gene to be activated but also a variety of 
other genes [57]. SW’12 is in fact identical to SNF2 and 
SWIl is ADR6, a gene required for transcription of 
ADHf and ADHZ. It has been suggested that SWII, -2 
and -3 and SNFS and -6 may UC components of a large 
multisubunit complex and that they may function as 
coactivators [ST. However, since mutations that alter 
histone H3 or inactivate an HMG l-like protein allevi- 
ate the effects of the swi- mutations (see [57] for refs.) 
it is equally possible that the role of the SWII, -2 and 
-3 products is to alter chromatin structure so as to make 
promoters accessible to gene-specific activators. This 
serves to emphasize the point that whilst direct protein- 
protein contacts between activators and the general 
transcription factors will play an important role in tran- 
scriptional activation, it is also essential to consider the 
interactions between activators and chromatin. 
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